Two Sigma Investments
AZN icon

Two Sigma Investments’s AstraZeneca AZN Stock Holding History

Two Sigma Investments’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.18M Buy
+6,000
New +$1.16M ﹤0.01% 3134

Other funds holding AZN

IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VAM
Vanguard Asset Management London, Ec4n 8af $117B AUM

Two Sigma Investments's AZN Position: Q1 2026 in Review

Two Sigma Investments reduced its AstraZeneca (AZN) stake by 81% in Q1 2026, selling an estimated $171M and leaving 203,026 shares worth $40M. The position accounts for 0.03% of the portfolio, ranked #593.

Two Sigma Investments first reported a position in AZN in Q2 2013 and has held it in 41 quarters since. The position peaked at $216M in Q1 2024. 1,378 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

  • Two Sigma Investments held 203,026 shares of AstraZeneca worth $40M as of Q1 2026.
  • Two Sigma Investments sold 887,212 AstraZeneca shares in Q1 2026, an estimated $171M.
  • AstraZeneca made up 0.03% of Two Sigma Investments's portfolio in Q1 2026, its #593 holding.
  • Two Sigma Investments first reported a position in AstraZeneca in Q2 2013 and has held it in 41 quarters since.
  • Two Sigma Investments's AstraZeneca position peaked at $216M in Q1 2024.
  • 1,378 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Two Sigma Investments's 13F filing for Q1 2026, filed 15 May 2026.